From: Thymidine Phosphorylase/β-tubulin III expressions predict the response in Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel
TUBB3 Staining
Positive
Negative
CR+PR No.
8
SD No.
9
2
PD No.
5
1
Response rate (%)
36.4
72.7
P
0.049
Median PFS (days)
(95% CI)
86
(40.9-131.1)
237
(19.4-454.6)
0.046
Median OS (days)
201
(182.5-253.5)
388
(67.6-708.4)
0.029